Gain insight on how genetics may impact medications

Learn more about the GeneSight® test

PatientsClinicians

What is the GeneSight test?

GeneSight Psychotropic is a pharmacogenomic test which means that it analyzes how your genes may affect medication outcomes. The GeneSight test analyzes clinically important genetic variations in your DNA. Results can inform your healthcare provider about how you may break down or respond to certain medications commonly prescribed to treat depression, anxiety, ADHD, and other psychiatric conditions.

The GeneSight test must be ordered by your healthcare provider or nurse practitioner. The test is a simple cheek swab taken in your healthcare provider’s office or can be sent by your healthcare provider to be taken in the convenience of your home.

Learn more

See the GeneSight test process

3,000,000+ people have taken the GeneSight test

Cost shouldn’t be a barrier

If you have insurance, we will bill your insurance for the cost of the GeneSight test. Some insurance plans will cover the cost though this can vary.

Insurance type Typical Cost
Medicare (part B) $0 out of pocket
Medicaid $0 out of pocket
Medicare advantage (part C),
commercial or other $330 or less
Uninsured $330* or less

*Reduced self-pay cost

The GeneSight Promise

If you decide to use your insurance and we determine that your cost will exceed $330, we will contact you before processing the test and before billing you to make sure you would like to proceed.

Reduced self-pay option

All patients are eligible for the reduced self-pay option of $330. Self-pay may be the most affordable option for patients whose out-of-pocket cost is estimated to be higher than $330, for those whose insurance does not cover the GeneSight test, or for those without insurance.

Learn more about cost

A comprehensive report,
personalized for you

The GeneSight test report may help you avoid multiple medication trials by providing information about which medications may require dose adjustments, be less likely to work, or have an increased risk of side effects based on your genetic information.

The report also includes information on how a patient’s smoking status may affect their body’s metabolism of certain medications.

Learn more
  •  Use as directed
  •  Moderate gene-drug interaction
  •  Significant gene-drug interaction

The report classifies over 60 mental health medications into three categories.

The GeneSight test results do not provide information on disease diagnosis, medication allergies, drug-drug interactions, or which medications will work best.

Backed by extensive research

7 clinical studies published in peer-reviewed journals support the GeneSight test’s effectiveness.

GUIDED clinical study

The largest patient and rater blinded pharmacogenomic study in mental health.1

Key findings

The GeneSight test outperformed treatment as usual.

>11%

relative improvement in depressive symptoms2

>30%

relative improvement in response rates3

>50%

relative improvement in remission rates4

Learn more

The GeneSight test process

The GeneSight test is administered by your healthcare provider in their office or at the comfort of your own home.

Click an icon to learn more.

Step 1

Collection

Your provider collects a DNA sample by painlessly swabbing the inside of your cheek OR you can collect the sample at home using our patient collection kit.

Step 2

Lab

The sample is sent to our lab for analysis.

Step 3

Results

After we receive your sample, your healthcare provider will typically get test results in about 2 days.

Step 4

Consultation

Your provider can contact our Medical Affairs team for a consultation. Your provider can then review the results with you on your next visit.

Step 1

Collection

Your provider collects a DNA sample by painlessly swabbing the inside of your cheek OR you can collect the sample at home using our patient collection kit.

Step 2

Lab

The sample is sent to our lab for analysis.

Step 3

Results

After we receive your sample, your healthcare provider will typically get test results in about 2 days.

Step 4

Consultation

Your provider can contact our Medical Affairs team for a consultation. Your provider can then review the results with you on your next visit.

    Take the next step

    Hear from others
like you

    "I was so impressed with the GeneSight testing"

    Sami S., Ohio
    I’ve seen more stability and not as many side effects
    Justin, North Dakota

    "I’ve seen more stability and not as many side effects"

    Read more

    I’ve been through so much now I have hope
    Cheryl M., Utah

    "I’ve been through so much now I have hope"

    Read more

    Thank you for offering this test
    Amanda L., Ohio

    "Thank you for offering this test"

    Read more

      The stories shared on this page are individual patients’ personal experiences with GeneSight. Others may not have the same experience or outcome. Do not make any changes to your current medications or dosing without consulting your healthcare provider. The GeneSight test must be ordered by and used only in consultation with a healthcare provider who can prescribe medications.

      Take the next step with the GeneSight test

      Take a step closer to getting the GeneSight test or registering to provide the test to your patients. We will follow up with additional information either via email or phone.

      The GeneSight test must be ordered by a registered clinician. If you are a patient, caregiver or office staff who would like a clinician to be registered to administer the GeneSight test, please include their name and contact information.

      If you are a current registered provider or tested patient, please contact us.

      Take the Next Step - PD

      1. Step 1
      2. Step 2
      3. Step 3
      Please provide us with your name



      1. Step 1
      2. Step 2
      3. Step 3
      Please provide contact and clinic information
      Please provide contact information

      We are asking for Date of Birth for data verification purposes.










      We are asking for Date of Birth for data verification purposes.

      If you do not have a clinician, we have a directory of healthcare providers who are registered to order the GeneSight test. When you complete this form, we will link you to this directory, so you will have the option to view registered GeneSight providers in your area.







      Your clinician who is currently managing your medication and making treatment decisions can order your GeneSight test.

      If you do not have a clinician, we have a directory of healthcare providers who are registered to order the GeneSight test. When you complete this form, we will link you to this directory, so you will have the option to view registered GeneSight providers in your area.

      Please provide your clinician's information
      The GeneSight test must be ordered by your clinician








      1. Step 1
      2. Step 2
      3. Step 3

      How can we help?
      When completed, we'll follow up with more information
      Please let us know how we can best help you
      When completed, we'll follow up with more information

      If you are a patient or a caregiver and would like to request a copy of your results, please complete the Patient Report Request form here









      Contact Information

      By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Take the Next Step” page you agree to the possible transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be utilized for the sole purpose it was submitted for and governed by our Privacy Notice.

      *Based on a review of six months of past claim data for major insurance carriers across the US. Last updated 2023.

      1. The GUIDED Clinical Study was an 8-week, blinded, randomized controlled trial of 1,167 subjects with major depressive disorder from 20 academic sites and 40 community sites.
      2. The primary endpoint of symptom improvement did not achieve statistical significance (p=0.107). Absolute improvement of 3%.
      3. Secondary endpoint of response achieved statistical significance (p=0.013). Absolute improvement of 6%
      4. Secondary endpoint of remission achieved statistical significance (p=0.007). Absolute improvement of 5%